iShares Genomics Immunology and Healthcare ETF Rating $22.65 -0.54 (-2.33%) Closing price 09/12/2025 04:10 PM EasternExtended Trading$22.64 -0.01 (-0.07%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.68Holdings in IDNA have an aggregate rating of Moderate Buy based on 233 analyst ratings issued in the past year covering 17 companies (54.7% of the portfolio).IDNA Aggregate Price Target$22.65High Prediction$22.65Average Prediction$22.65Low Prediction$22.65Holdings in IDNA have an aggregate price target of $22.65 and a range of $22.65 to $22.65 covering 17 companies (54.7% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy5 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.82%INCYIncyte$83.10-3.6%4.7526 of 5 stars2.33$82.53 -0.7%18Positive NewsAnalyst DowngradeShort Interest ↓4.66%REGNRegeneron Pharmaceuticals$560.00-1.4%4.7652 of 5 stars2.82$817.67 46.0%28Positive NewsShort Interest ↑4.18%MRKMerck & Co., Inc.$82.87-2.7%4.9965 of 5 stars2.35$107.44 29.6%20News CoveragePositive News4.09%ACLXArcellx$76.19-1.9%2.3652 of 5 stars3.13$114.31 50.0%15News CoveragePositive News3.77%CELCCelcuity$54.91-4.4%1.316 of 5 stars3.00$56.50 2.9%4News CoveragePositive News3.72%BNTXBioNTech$96.74-7.3%2.5143 of 5 stars2.76$135.80 40.4%17Gap DownHigh Trading Volume3.70%RVMDRevolution Medicines$46.55+0.7%4.2161 of 5 stars3.07$73.67 58.3%15Trending NewsAnalyst ForecastAnalyst Revision3.53%MRNAModerna$23.51-7.4%4.4614 of 5 stars2.05$41.81 77.8%22Trending NewsHigh Trading Volume3.49%EXELExelixis$39.15+0.2%4.6983 of 5 stars2.52$44.06 12.5%23Positive News3.34%TWSTTwist Bioscience$25.31-1.2%3.9629 of 5 stars2.73$49.40 95.2%11News Coverage3.04%BCRXBioCryst Pharmaceuticals$7.91-2.0%4.2557 of 5 stars2.90$16.70 111.1%10Positive News2.56%JANXJanux Therapeutics$24.05-4.3%2.6457 of 5 stars3.07$80.92 236.5%15News CoverageAnalyst Forecast2.50%NVAXNovavax$7.98-3.6%4.4835 of 5 stars2.13$14.29 79.0%8Positive News2.16%ABCLAbCellera Biologics$4.47-3.0%2.753 of 5 stars3.00$8.00 79.0%61.93%GERNGeron$1.27-3.8%3.1317 of 5 stars2.29$3.79 198.1%7Positive News1.70%IMNMImmunome$9.21-4.9%2.3188 of 5 stars3.00$22.89 148.5%9Positive NewsHigh Trading Volume1.53%RIGLRigel Pharmaceuticals$37.96+0.4%2.0481 of 5 stars2.40$38.20 0.6%5News CoveragePositive NewsShort Interest ↓ This page (NYSEARCA:IDNA) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDNA Stock Alerts